Literature DB >> 3965299

Structural characterization of a blood group A heptaglycosylceramide with globo-series structure. The major glycolipid based blood group A antigen of human kidney.

M E Breimer, P A Jovall.   

Abstract

A blood group A glycosphingolipid with the globo-series structure has been isolated from human kidney and structurally characterized. The structure was shown by mass spectrometry and proton NMR spectroscopy of the intact permethylated and permethylated-reduced derivatives together with degradation studies to be, GalNAc alpha 1----3Gal(2----1 alpha Fuc)beta 1----3GalNAc beta 1----3Gal alpha 1----4Gal beta 1----4Glc beta 1----1 Ceramide. This glycolipid reacts with both polyclonal and monoclonal anti-A blood group typing antisera and it is the major glycolipid based blood group A antigen present in the human kidney.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3965299     DOI： 10.1016/0014-5793(85)80213-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


  13 in total

1.  pap-2-encoded fimbriae adhere to the P blood group-related glycosphingolipid stage-specific embryonic antigen 4 in the human kidney.

Authors:  J F Karr; B J Nowicki; L D Truong; R A Hull; J J Moulds; S I Hull
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

2.  Binding specificities of wild-type and cloned Escherichia coli strains that recognize globo-A.

Authors:  R Lindstedt; N Baker; P Falk; R Hull; S Hull; J Karr; H Leffler; C Svanborg Edén; G Larson
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

3.  Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate.

Authors:  V Kudryashov; G Ragupathi; I J Kim; M E Breimer; S J Danishefsky; P O Livingston; K O Lloyd
Journal:  Glycoconj J       Date:  1998-03       Impact factor: 2.916

4.  Influence of blood group on the availability of receptors for attachment of uropathogenic Escherichia coli.

Authors:  H Lomberg; B Cedergren; H Leffler; B Nilsson; A S Carlström; C Svanborg-Edén
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

5.  Glycolipid- and glycoprotein-based blood group A antigen expression in human thrombocytes. A1/A2 difference.

Authors:  J Holgersson; M E Breimer; A Jacobsson; L Svensson; A Ulfvin; B E Samuelsson
Journal:  Glycoconj J       Date:  1990       Impact factor: 2.916

6.  Blood group type glycosphingolipids of human kidneys. Structural characterization of extended globo-series compounds.

Authors:  J Holgersson; P A Jovall; B E Samuelsson; M E Breimer
Journal:  Glycoconj J       Date:  1991-10       Impact factor: 2.916

7.  Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status.

Authors:  A Stapleton; E Nudelman; H Clausen; S Hakomori; W E Stamm
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

Review 8.  Strategies to overcome the ABO barrier in kidney transplantation.

Authors:  Georg A Böhmig; Andreas M Farkas; Farsad Eskandary; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2015-09-01       Impact factor: 28.314

9.  Host-specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gal alpha 1-4Gal-containing isoreceptors.

Authors:  N Strömberg; B I Marklund; B Lund; D Ilver; A Hamers; W Gaastra; K A Karlsson; S Normark
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

10.  Expression of histo-blood group A type 1, 2 and 3 antigens in normal skin and extramammary Paget's disease.

Authors:  Aki Tanaka; Akihiko Kimura; Yuki Yamamoto; Koji Uede; Fukumi Furukawa
Journal:  Acta Histochem Cytochem       Date:  2008-10-30       Impact factor: 1.938
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.